Jul 1 |
TriSalus Life Sciences Announces Completion of Exchange Offer and Consent Solicitation
|
Jun 26 |
TriSalus Life Sciences Announces Expiration and Results of Exchange Offer and Consent Solicitation Relating to Warrants
|
May 15 |
TriSalus Life Sciences, Inc. (TLSI) Q1 2024 Earnings Call Transcript
|
May 15 |
TriSalus Life Sciences reports Q1 GAAP EPS of -$0.60, revenue of $6.5M
|
May 15 |
TriSalus Reports Q1 2024 Financial Results and Business Update
|
May 7 |
TriSalus Life Sciences Appoints Liselotte Hyveled to its Board of Directors
|
May 6 |
TriSalus Life Sciences to Host First Quarter 2024 Financial Results Conference Call
|
May 1 |
TriSalus Life Sciences secures ~$50M of debt financing with OrbiMed
|
Apr 30 |
TriSalus Life Sciences Secures up to $50 million of Debt Financing with OrbiMed to Support TriNavĀ® Infusion System Growth Initiatives
|
Apr 1 |
TriSalus Life Sciences, Inc. (TLSI) Q4 2023 Earnings Call Transcript
|